Literature DB >> 16455625

PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.

Jae Seung Kim1, Masanori Ichise, Janet Sangare, Robert B Innis.   

Abstract

UNLABELLED: Parametric imaging of serotonin transporters (SERT) with 11C-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)benzonitrile ([11C]DASB) PET is a useful data analysis tool. The purpose of this study was to evaluate the reproducibility of measurements of SERT binding potential (BP) and relative blood flow (R1) by a 2-parameter multilinear reference tissue parametric imaging method (MRTM2) for human [11C]DASB studies.
METHODS: Eight healthy subjects (3 men, 5 women; age, 26 +/- 9 y) underwent 2 [11C]DASB PET scans separated by 1 h on the same day (dose, 703 +/- 111 MBq). Parametric images of BP and R1 were generated by MRTM2 using the cerebellum as a reference region. The k'2 (clearance rate constant from the reference region) required by MRTM2 was estimated by the 3-parameter MRTM. Reproducibility of BP and R1 measurements was evaluated by calculating bias (100 x (retest - test/test), variability (SD of the bias), and reliability (intraclass correlation coefficient = rho) for several representative regions of interest (ROIs). BP and R1 were estimated for ROI time-activity curves fitted by MRTM2 and were compared with those based on the parametric images.
RESULTS: The test-retest (0.066 +/- 0.013/0.06 +/- 0.011 min(-1)) MRTM k'2 reproducibility was excellent with small bias (3%) and variability (6%) and high reliability (0.95). Retest BP values were consistently lower than those of test BP values in all regions (a mean negative bias of approximately 6%; P < 0.001). The test-retest BP variability was relatively small, ranging from 4% to 13%, with rho ranging from 0.44 to 0.85. In contrast to BP, test-retest R1 values were similar with negligible bias of < or =0.1%. The test-retest R1 variability was excellent and smaller than that of BP ranging from 3% to 6%, with rho ranging from 0.58 to 0.95. BP and R1 values estimated by the ROI time-activity curve-fitting method were slightly lower ( approximately 3% and approximately 1%, respectively) than those by the parametric imaging method (P < 0.001). However, the test-retest bias and variability of BP and R1 were very similar for both ROI and parametric methods.
CONCLUSION: Our results suggest that [11C]DASB parametric imaging of BP and R1 with the noninvasive MRTM2 method is reproducible and reliable for PET studies of SERT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455625

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  28 in total

1.  PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.

Authors:  Fumihiko Yasuno; Sandra M Sanabria; Donald Burns; Richard J Hargreaves; Subroto Ghose; Masanori Ichise; Frederick T Chin; Cheryl L Morse; Victor W Pike; Robert B Innis
Journal:  Synapse       Date:  2007-04       Impact factor: 2.562

2.  Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.

Authors:  Aybala Saricicek; Jason Chen; Beata Planeta; Barbara Ruf; Kalyani Subramanyam; Kathleen Maloney; David Matuskey; David Labaree; Lorenz Deserno; Alexander Neumeister; John H Krystal; Jean-Dominique Gallezot; Yiyun Huang; Richard E Carson; Zubin Bhagwagar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-27       Impact factor: 9.236

3.  Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen
Journal:  Neuroimage       Date:  2019-06-01       Impact factor: 6.556

4.  In vivo variation in same-day estimates of metabotropic glutamate receptor subtype 5 binding using [11C]ABP688 and [18F]FPEB.

Authors:  Christine DeLorenzo; Jean-Dominique Gallezot; John Gardus; Jie Yang; Beata Planeta; Nabeel Nabulsi; R Todd Ogden; David C Labaree; Yiyun H Huang; J John Mann; Fabrizio Gasparini; Xin Lin; Jonathan A Javitch; Ramin V Parsey; Richard E Carson; Irina Esterlis
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.

Authors:  Masanori Ichise; Douglass C Vines; Tami Gura; George M Anderson; Stephen J Suomi; J Dee Higley; Robert B Innis
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

6.  Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Ling Feng; Masanori Ichise; Rupert Lanzenberger; Mark Lubberink; Ramin V Parsey; Marios Politis; Eugenii A Rabiner; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; Peter S Talbot; Federico Turkheimer; Stephen C Strother; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-13       Impact factor: 6.200

7.  Different preprocessing strategies lead to different conclusions: A [11C]DASB-PET reproducibility study.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-01       Impact factor: 6.200

8.  Test-Retest Reliability of the SERT Imaging Agent 11C-HOMADAM in Healthy Humans.

Authors:  Vikram Adhikarla; Boadie W Dunlop; Nashwa Jarkas; Mark M Goodman; Helen Mayberg; Michael J Owens; Jonathon A Nye
Journal:  J Nucl Med       Date:  2017-09-21       Impact factor: 10.057

9.  11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.

Authors:  Robin Goland; Matthew Freeby; Ramin Parsey; Yoshifumi Saisho; Dileep Kumar; Norman Simpson; Joy Hirsch; Martin Prince; Antonella Maffei; J John Mann; Peter C Butler; Ronald Van Heertum; Rudolph L Leibel; Masanori Ichise; Paul E Harris
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

10.  Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.

Authors:  Dima A Hammoud; Christopher J Endres; Edward Hammond; Ovsev Uzuner; Amanda Brown; Avindra Nath; Adam I Kaplin; Martin G Pomper
Journal:  Neuroimage       Date:  2009-10-21       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.